Tag - opioid dependence

Feature

Titan Pharma advancing pipeline in PD, other disorders

By Len Zehr Titan Pharmaceuticals (NASDAQ:TTNP), which is awaiting an FDA approval decision for its six-month Probuphine implant to treat opioid dependence, is advancing its ProNeura implant technology against...

October 13, 2015

Feature

Titan implanting treatments for opioid dependence

By Len Zehr In the continuing struggle to circumvent abuse of drugs to treat opioid dependence and enhance compliance regimes for better outcomes, Titan Pharmaceuticals (OTCBB:TTNP) is leading the race with a matchstick...

August 19, 2014

Tag - opioid dependence

Titan Pharma advancing pipeline in PD, other disorders

Titan implanting treatments for opioid dependence

General

More